Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
Evidence[PMID] |
TMEM217 |
transmembrane protein 217 |
6p21.31-p21.2 |
1(0/0/1)
|
IEA
|
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
NAS[8145738]
|
SLC18A1 |
solute carrier family 18 (vesicular monoamine transporter), member 1 |
8p21.3 |
3(2/1/0)
|
IEA
|
CSMD3 |
CUB and Sushi multiple domains 3 |
8q23.3 |
1(0/1/0)
|
IEA
|
NOTCH3 |
notch 3 |
19p13.2-p13.1 |
1(0/1/0)
|
IEA
|
DNAJC16 |
DnaJ (Hsp40) homolog, subfamily C, member 16 |
1p36.1 |
1(0/1/0)
|
IEA
|
GPR124 |
adhesion G protein-coupled receptor A2 |
8p11.22 |
0
|
IEA
|
TAOK2 |
TAO kinase 2 |
16p11.2 |
1(0/1/0)
|
IEA
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
3(1/2/0)
|
IEA
|
SLC6A5 |
solute carrier family 6 (neurotransmitter transporter), member 5 |
11p15.1 |
1(0/1/0)
|
IEA
|
HEPACAM2 |
HEPACAM family member 2 |
7q21.3 |
1(0/0/1)
|
IEA
|
FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
NAS[1697263]
|
EVC |
Ellis van Creveld syndrome |
4p16 |
1(0/0/1)
|
IEA
|
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
6q25.2 |
6(3/2/1)
|
IDA[11792814]
|
OPA1 |
optic atrophy 1 (autosomal dominant) |
3q29 |
1(0/1/0)
|
IEA
|
PRLR |
prolactin receptor |
5p14-p13 |
1(1/0/0)
|
IEA
|
OR2Y1 |
olfactory receptor, family 2, subfamily Y, member 1 |
5q35 |
1(0/0/1)
|
IEA
|
GGTA1P |
glycoprotein, alpha-galactosyltransferase 1 pseudogene |
9q33.2 |
1(1/0/0)
|
IEA
|
DPP10 |
dipeptidyl-peptidase 10 (non-functional) |
2q14.1 |
3(2/1/0)
|
IEA
|
PTPRT |
protein tyrosine phosphatase, receptor type, T |
20q12-q13 |
2(0/1/1)
|
NAS[9602027]
|
ABCC12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
16q12.1 |
1(0/1/0)
|
IEA
|
DIO2 |
deiodinase, iodothyronine, type II |
14q24.2-q24.3 |
1(1/0/0)
|
IEA
|
KCND2 |
potassium channel, voltage gated Shal related subfamily D, member 2 |
7q31 |
1(1/0/0)
|
IBA
|
ABHD2 |
abhydrolase domain containing 2 |
15q26.1 |
2(0/1/1)
|
IEA
|
LRRC15 |
leucine rich repeat containing 15 |
3q29 |
1(0/1/0)
|
IEA
|
MALL |
mal, T-cell differentiation protein-like |
2q13 |
1(0/1/0)
|
IEA
|
NAALAD2 |
N-acetylated alpha-linked acidic dipeptidase 2 |
11q14.3-q21 |
1(0/1/0)
|
NAS[10085079]
|
LMBR1L |
limb development membrane protein 1-like |
12q13.12 |
1(0/0/1)
|
IEA
|
CDH7 |
cadherin 7, type 2 |
18q22.1 |
1(0/0/1)
|
IEA
|
THSD7A |
thrombospondin, type I, domain containing 7A |
7p21.3 |
1(1/0/0)
|
IEA
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
IEA
|
ASTN2 |
astrotactin 2 |
9q33 |
1(1/0/0)
|
IEA
|
ZDHHC8 |
zinc finger, DHHC-type containing 8 |
22q11.21 |
1(0/1/0)
|
IEA
|
SLC39A3 |
solute carrier family 39 (zinc transporter), member 3 |
19p13.3 |
1(0/1/0)
|
IEA
|
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
15q26 |
2(1/1/0)
|
IEA
|
ATP6V0A2 |
ATPase, H+ transporting, lysosomal V0 subunit a2 |
12q24.31 |
1(0/1/0)
|
IEA
|
BET1 |
Bet1 golgi vesicular membrane trafficking protein |
7q21.1-q22 |
1(1/0/0)
|
IEA
|
TMEM108 |
transmembrane protein 108 |
3q22.1 |
1(1/0/0)
|
IEA
|
MPPE1 |
metallophosphoesterase 1 |
18p11.21 |
2(2/0/0)
|
IEA
|
CLDN16 |
claudin 16 |
3q28 |
1(0/1/0)
|
IEA
|
SEL1L2 |
sel-1 suppressor of lin-12-like 2 (C. elegans) |
20p12.1 |
1(0/1/0)
|
IEA
|
TYR |
tyrosinase |
11q14.3 |
1(0/1/0)
|
IEA
|
ALG10B |
ALG10B, alpha-1,2-glucosyltransferase |
12q12 |
1(0/1/0)
|
IEA
|
GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
9q31.1 |
1(0/1/0)
|
NAS[11880201]
|
MFSD11 |
major facilitator superfamily domain containing 11 |
17q25.1 |
1(0/1/0)
|
IEA
|
VAMP7 |
vesicle-associated membrane protein 7 |
Xq28 and Yq12 |
2(0/2/0)
|
IEA
|
TAAR1 |
trace amine associated receptor 1 |
6q23.1 |
1(0/1/0)
|
IC[15718104]
|
EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IEA
|
PCDH15 |
protocadherin-related 15 |
10q21.1 |
4(2/1/1)
|
IEA
|
ATP13A4 |
ATPase type 13A4 |
3q29 |
1(0/1/0)
|
IEA
|
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
2p15-p13 |
1(0/1/0)
|
NAS[8101838]
|
ZDHHC13 |
zinc finger, DHHC-type containing 13 |
11p15.1 |
1(0/0/1)
|
IEA
|
DIO3 |
deiodinase, iodothyronine, type III |
14q32 |
1(0/1/0)
|
IEA
|
ACE |
angiotensin I converting enzyme |
17q23.3 |
5(2/3/0)
|
IEA
|
RNF144B |
ring finger protein 144B |
6p22.3 |
1(1/0/0)
|
IEA
|
TPST2 |
tyrosylprotein sulfotransferase 2 |
22q12.1 |
2(1/0/1)
|
IEA
|
PILRA |
paired immunoglobin-like type 2 receptor alpha |
7q22.1 |
1(0/0/1)
|
IEA
|
GALNT13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
2q24.1 |
1(0/1/0)
|
IEA
|
B3GALT5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
21q22.3 |
1(0/0/1)
|
IEA
|
COX10 |
COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor |
17p12 |
1(1/0/0)
|
IEA
|
ATP1A3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
19q13.2 |
3(2/1/0)
|
NAS[15260953]
|
EXTL1 |
exostosin-like glycosyltransferase 1 |
1p36.1 |
1(1/0/0)
|
IEA
|
IL15RA |
interleukin 15 receptor, alpha |
10p15.1 |
1(1/0/0)
|
IEA
|
SCN8A |
sodium channel, voltage gated, type VIII alpha subunit |
12q13.1 |
1(1/0/0)
|
TAS[9828131]
|
THSD7B |
thrombospondin, type I, domain containing 7B |
2q22.1 |
1(1/0/0)
|
IEA
|
GPR78 |
G protein-coupled receptor 78 |
4p16.1 |
2(2/0/0)
|
IEA
|
UPK3B |
uroplakin 3B |
7q11.2 |
1(0/0/1)
|
IEA
|
TAS1R3 |
taste receptor, type 1, member 3 |
1p36 |
1(0/0/1)
|
IC[11917125]
|
LINGO2 |
leucine rich repeat and Ig domain containing 2 |
9p21.2 |
1(0/0/1)
|
IEA
|
FZD2 |
frizzled class receptor 2 |
17q21.1 |
1(0/1/0)
|
IBA
|
FAR2 |
fatty acyl CoA reductase 2 |
12p11.23 |
1(0/1/0)
|
IEA
|
SRD5A1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
5p15.31 |
1(1/0/0)
|
IEA
|
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
9q21.13 |
1(1/0/0)
|
IEA
|
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
15q24 |
3(1/2/0)
|
NAS[8906617]
|
LHFPL3 |
lipoma HMGIC fusion partner-like 3 |
7q22.2 |
1(0/1/0)
|
IEA
|
MUC16 |
mucin 16, cell surface associated |
19p13.2 |
1(0/0/1)
|
IEA
|
FAAH |
fatty acid amide hydrolase |
1p35-p34 |
2(0/2/0)
|
IEA
|
MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
4(2/2/0)
|
IEA
|
SEZ6L |
seizure related 6 homolog (mouse)-like |
22q12.1 |
1(1/0/0)
|
IEA
|
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
NAS[8906617]
|
KCNQ2 |
potassium channel, voltage gated KQT-like subfamily Q, member 2 |
20q13.33 |
1(1/0/0)
|
IBA
|
SLC30A8 |
solute carrier family 30 (zinc transporter), member 8 |
8q24.11 |
1(1/0/0)
|
IEA
|
VAPA |
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa |
18p11.2 |
1(1/0/0)
|
IEA
|
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
7q21.12 |
1(1/0/0)
|
IBA
|
PTPRE |
protein tyrosine phosphatase, receptor type, E |
10q26 |
1(1/0/0)
|
IEA
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
IEA
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
TAS[8628395]
|
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
5p15.2 |
1(1/0/0)
|
IEA
|
ASTN1 |
astrotactin 1 |
1q25.2 |
1(1/0/0)
|
IEA
|
SLC25A21 |
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 |
14q13.3 |
1(0/0/1)
|
IEA
|
FAM20B |
family with sequence similarity 20, member B |
1q25.2 |
1(0/1/0)
|
IEA
|
TM4SF19 |
transmembrane 4 L six family member 19 |
3q29 |
1(0/1/0)
|
IBA
|
SLC22A23 |
solute carrier family 22, member 23 |
6p25.2 |
1(1/0/0)
|
IEA
|
MAOA |
monoamine oxidase A |
Xp11.4-p11.3 |
21(10/11/0)
|
IEA
|
SLC9A3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
5p15.3 |
1(1/0/0)
|
IEA
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
IEA
|
PTPRO |
protein tyrosine phosphatase, receptor type, O |
12p13-p12 |
1(0/1/0)
|
TAS[10498613]
|
ITPRIPL2 |
inositol 1,4,5-trisphosphate receptor interacting protein-like 2 |
16p12.3 |
1(0/0/1)
|
IEA
|
VAMP3 |
vesicle-associated membrane protein 3 |
1p36.23 |
1(0/1/0)
|
IEA
|
GLT8D1 |
glycosyltransferase 8 domain containing 1 |
3p21.1 |
1(1/0/0)
|
IEA
|
ADAM18 |
ADAM metallopeptidase domain 18 |
8p11.22 |
1(0/0/1)
|
IEA
|
CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
4(2/2/0)
|
IDA[23863939]
|
LAMP3 |
lysosomal-associated membrane protein 3 |
3q26.3-q27 |
1(1/0/0)
|
IEA
|
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
11p13-p12 |
1(1/0/0)
|
IEA
|
ZAN |
zonadhesin (gene/pseudogene) |
7q22.1 |
1(0/0/1)
|
IEA
|
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
1p13 |
1(1/0/0)
|
ISS
|
TMEM151B |
transmembrane protein 151B |
6p21.1 |
1(1/0/0)
|
IEA
|
TBXAS1 |
thromboxane A synthase 1 (platelet) |
7q34-q35 |
1(0/1/0)
|
IEA
|
SORCS2 |
sortilin-related VPS10 domain containing receptor 2 |
4p16.1 |
5(3/2/0)
|
IEA
|
SLC22A16 |
solute carrier family 22 (organic cation/carnitine transporter), member 16 |
6q21 |
1(1/0/0)
|
IDA[12089149]
|
ATRNL1 |
attractin-like 1 |
10q26 |
1(0/1/0)
|
IEA
|
ADAM12 |
ADAM metallopeptidase domain 12 |
10q26 |
1(1/0/0)
|
IEA
|
NCAM1 |
neural cell adhesion molecule 1 |
11q23.2 |
3(2/1/0)
|
IEA
|
HS3ST4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
16p11.2 |
1(1/0/0)
|
IEA
|
FMO5 |
flavin containing monooxygenase 5 |
1q21.1 |
1(1/0/0)
|
IEA
|
ZDHHC19 |
zinc finger, DHHC-type containing 19 |
3q29 |
1(0/1/0)
|
IEA
|
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
2q12 |
1(0/0/1)
|
IEA
|
B3GALT1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
2q24.3 |
1(1/0/0)
|
NAS[9582303]
|
CERS3 |
ceramide synthase 3 |
15q26.3 |
1(0/0/1)
|
IEA
|
ESR1 |
estrogen receptor 1 |
6q24-q27 |
1(0/1/0)
|
IEA
|
FER1L6 |
fer-1-like family member 6 |
8q24.13 |
1(0/1/0)
|
IEA
|
PITPNM2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
12q24.31 |
1(0/1/0)
|
NAS[10022914]
|
DPP6 |
dipeptidyl-peptidase 6 |
7q36.2 |
2(1/1/0)
|
IDA[18364354]
|
GLRA1 |
glycine receptor, alpha 1 |
5q33.1 |
1(1/0/0)
|
NAS[15952785]
|
ALG9 |
ALG9, alpha-1,2-mannosyltransferase |
11q23 |
1(0/1/0)
|
IEA
|
OR3A1 |
olfactory receptor, family 3, subfamily A, member 1 |
17p13.3 |
1(0/0/1)
|
IBA
|
SYNGR1 |
synaptogyrin 1 |
22q13 |
3(2/1/0)
|
IEA; NAS[9760194]
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
20(17/3/0)
|
IDA[8392192]
|
CMTM8 |
CKLF-like MARVEL transmembrane domain containing 8 |
3p22.2 |
2(1/1/0)
|
IEA
|
TMEM132E |
transmembrane protein 132E |
17q12 |
1(0/0/1)
|
IEA
|
NRXN2 |
neurexin 2 |
11q13 |
1(1/0/0)
|
IEA
|
CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
8p11.21 |
3(1/2/0)
|
NAS[8906617]
|
SERINC1 |
serine incorporator 1 |
6q22.32 |
1(1/0/0)
|
IEA
|
SRD5A2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
2p23.1 |
1(0/1/0)
|
IEA
|
FLVCR2 |
feline leukemia virus subgroup C cellular receptor family, member 2 |
14q24.3 |
1(1/0/0)
|
IEA
|
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
Xq26.2 |
1(0/0/1)
|
IEA
|
CHL1 |
cell adhesion molecule L1-like |
3p26 |
1(1/0/0)
|
IEA
|
LRBA |
LPS-responsive vesicle trafficking, beach and anchor containing |
4q13 |
1(0/0/1)
|
IEA
|
CDHR3 |
cadherin-related family member 3 |
7q22.2 |
1(0/1/0)
|
IEA
|
SEC63 |
SEC63 homolog (S. cerevisiae) |
6q21 |
1(1/0/0)
|
IEA
|
GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
IDA[12746871]
|
HCAR2 |
hydroxycarboxylic acid receptor 2 |
12q24.31 |
1(0/1/0)
|
IEA
|
POMGNT2 |
protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) |
3p22.1 |
1(0/0/1)
|
IEA
|
PVRIG |
poliovirus receptor related immunoglobulin domain containing |
7q22.1 |
1(0/0/1)
|
IEA
|
MLC1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
22q13.33 |
5(1/4/0)
|
IDA[17628813]
|
EDAR |
ectodysplasin A receptor |
2q13 |
1(0/1/0)
|
NAS[10431241]
|
SPTLC1 |
serine palmitoyltransferase, long chain base subunit 1 |
9q22.31 |
1(0/1/0)
|
IEA
|
STX12 |
syntaxin 12 |
1p35.3 |
1(0/1/0)
|
IBA
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
20q13.33 |
1(1/0/0)
|
NAS[8906617]
|
CMKLR1 |
chemokine-like receptor 1 |
12q23.3 |
1(0/1/0)
|
NAS[9603476]
|
OR4X2 |
olfactory receptor, family 4, subfamily X, member 2 (gene/pseudogene) |
11p11.2 |
1(0/0/1)
|
IBA
|
NMUR2 |
neuromedin U receptor 2 |
5q33.1 |
1(0/1/0)
|
IDA[10899166]
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
NAS[8906617]
|
LMAN2L |
lectin, mannose-binding 2-like |
2q11.1 |
2(2/0/0)
|
TAS[12609988]
|
XKR4 |
XK, Kell blood group complex subunit-related family, member 4 |
8q12.1 |
1(0/1/0)
|
IEA
|
TSPAN8 |
tetraspanin 8 |
12q14.1-q21.1 |
2(1/0/1)
|
IEA
|
DPY19L1 |
dpy-19-like 1 (C. elegans) |
7p14.3-p14.2 |
1(0/0/1)
|
IEA
|
PRSS55 |
protease, serine, 55 |
8p23.1 |
1(0/1/0)
|
IEA
|
SYPL1 |
synaptophysin-like 1 |
7q22.2 |
1(1/0/0)
|
TAS[1730063]
|
HLA-B |
major histocompatibility complex, class I, B |
6p21.3 |
2(0/1/1)
|
IEA
|
KCNN3 |
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 |
1q21.3 |
7(1/6/0)
|
IEA
|
PLD5 |
phospholipase D family, member 5 |
1q43 |
1(0/1/0)
|
IEA
|
DPCR1 |
diffuse panbronchiolitis critical region 1 |
6p21.32 |
1(0/0/1)
|
IEA
|
GLDN |
gliomedin |
15q15.3 |
1(1/0/0)
|
IEA
|
PROKR2 |
prokineticin receptor 2 |
20p12.3 |
1(1/0/0)
|
IEA
|
CSMD1 |
CUB and Sushi multiple domains 1 |
8p23.2 |
4(2/1/1)
|
IEA
|
DCC |
DCC netrin 1 receptor |
18q21.1 |
2(1/1/0)
|
IEA
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
28(14/14/0)
|
IEA
|
DPY19L3 |
dpy-19-like 3 (C. elegans) |
19q13.11 |
1(0/0/1)
|
IEA
|
JAM3 |
junctional adhesion molecule 3 |
11q25 |
2(1/1/0)
|
IEA
|
MCHR2 |
melanin-concentrating hormone receptor 2 |
6q16 |
1(1/0/0)
|
IEA
|
NDST3 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
4q26 |
1(1/0/0)
|
IEA
|
EDA2R |
ectodysplasin A2 receptor |
Xq11.1 |
1(0/0/1)
|
IC[12270937]
|
AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
NAS[8135787]
|
LEPR |
leptin receptor |
1p31 |
1(1/0/0)
|
IEA
|
SMCO1 |
single-pass membrane protein with coiled-coil domains 1 |
3q29 |
1(0/1/0)
|
IEA
|
FGFRL1 |
fibroblast growth factor receptor-like 1 |
4p16 |
1(0/0/1)
|
IEA
|
CHRFAM7A |
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion |
15q13.2 |
1(0/1/0)
|
IEA
|
KHDC1 |
KH homology domain containing 1 |
6q13 |
1(0/1/0)
|
IEA
|
CADM2 |
cell adhesion molecule 2 |
3p12.2 |
1(0/1/0)
|
IEA
|
DST |
dystonin |
6p12.1 |
1(0/0/1)
|
IEA
|
CNNM4 |
cyclin and CBS domain divalent metal cation transport mediator 4 |
2q11.2 |
1(1/0/0)
|
IEA
|
CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
8p21 |
3(0/3/0)
|
NAS[8906617]
|
OR1B1 |
olfactory receptor, family 1, subfamily B, member 1 (gene/pseudogene) |
9q33.2 |
1(0/1/0)
|
IBA
|
SLC2A9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
4p16.1 |
1(0/0/1)
|
NAS[10860667]
|
SDK1 |
sidekick cell adhesion molecule 1 |
7p22.3 |
1(1/0/0)
|
IEA
|
ARV1 |
ARV1 homolog (S. cerevisiae) |
1q42.2 |
1(0/0/1)
|
IEA
|
EVA1A |
eva-1 homolog A (C. elegans) |
2p12 |
1(1/0/0)
|
IEA
|
FZD3 |
frizzled class receptor 3 |
8p21 |
1(0/1/0)
|
IBA
|
FRMD3 |
FERM domain containing 3 |
9q21.33 |
1(0/1/0)
|
IEA
|
NRXN1 |
neurexin 1 |
2p16.3 |
1(1/0/0)
|
IEA
|
CNTNAP5 |
contactin associated protein-like 5 |
2q14.1 |
2(0/2/0)
|
IEA
|
LRP8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
1p32.3 |
1(1/0/0)
|
IC[11152697]
|
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
2q23-q24 |
1(1/0/0)
|
IEA
|
NRXN3 |
neurexin 3 |
14q31 |
2(2/0/0)
|
IEA
|
SLC12A6 |
solute carrier family 12 (potassium/chloride transporter), member 6 |
15q13 |
1(1/0/0)
|
NAS[10187864]
|
TAAR6 |
trace amine associated receptor 6 |
6q23.1 |
5(4/1/0)
|
IC[15718104]
|
MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
4q32.2 |
1(0/1/0)
|
IEA
|
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
3p12.3 |
1(0/1/0)
|
IEA
|
KCNQ3 |
potassium channel, voltage gated KQT-like subfamily Q, member 3 |
8q24 |
4(3/0/1)
|
IBA
|
NALCN |
sodium leak channel, non selective |
13q32.3 |
2(0/2/0)
|
IEA
|
ANO3 |
anoctamin 3 |
11p14.2 |
1(1/0/0)
|
IEA
|
TSPO |
translocator protein (18kDa) |
22q13.3 |
3(1/2/0)
|
IEA
|
CDH15 |
cadherin 15, type 1, M-cadherin (myotubule) |
16q24.3 |
1(1/0/0)
|
IEA
|
SLC5A12 |
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 |
11p14.2 |
1(1/0/0)
|
IEA
|
XBP1 |
X-box binding protein 1 |
22q12.1 |
3(2/1/0)
|
IEA
|
SGCZ |
sarcoglycan, zeta |
8p22 |
1(0/0/1)
|
IEA
|
IMMP2L |
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
7q31 |
1(1/0/0)
|
IEA
|
TAAR8 |
trace amine associated receptor 8 |
6q23.2 |
1(0/1/0)
|
IC[15718104]
|
POPDC3 |
popeye domain containing 3 |
6q21 |
1(1/0/0)
|
NAS[10882522]
|
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
2p21 |
1(0/1/0)
|
IEA
|
VRK2 |
vaccinia related kinase 2 |
2p16.1 |
1(0/1/0)
|
IEA
|
TMEM222 |
transmembrane protein 222 |
1p36.11 |
1(0/0/1)
|
IEA
|
XXYLT1 |
xyloside xylosyltransferase 1 |
3q29 |
2(0/2/0)
|
IEA
|
MPC2 |
mitochondrial pyruvate carrier 2 |
1q24 |
1(0/1/0)
|
IEA
|
VKORC1L1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
7q11.21 |
1(1/0/0)
|
IEA
|
BVES |
blood vessel epicardial substance |
6q21 |
1(1/0/0)
|
IDA[16188940]; NAS[10441744]
|
SGCG |
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
13q12-q13 |
2(0/2/0)
|
IEA
|
CD276 |
CD276 molecule |
15q23-q24 |
1(0/1/0)
|
NAS[15188059]
|